We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Horizon Discovery Introduces Whole Human Genome Arrayed Libraries to Support CRISPR Activation Screening
Product News

Horizon Discovery Introduces Whole Human Genome Arrayed Libraries to Support CRISPR Activation Screening

Horizon Discovery Introduces Whole Human Genome Arrayed Libraries to Support CRISPR Activation Screening
Product News

Horizon Discovery Introduces Whole Human Genome Arrayed Libraries to Support CRISPR Activation Screening


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Horizon Discovery Introduces Whole Human Genome Arrayed Libraries to Support CRISPR Activation Screening"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Horizon Discovery, a global leader in the application of gene editing and gene modulation to deliver inspired cell solutions, announced the introduction of Edit-R™ CRISPRa arrayed crRNA (CRISPR RNA) libraries, the latest addition to its CRISPR activation (CRISPRa) reagent platform from the recently acquired Dharmacon™ business. The new libraries offer a powerful tool for drug discovery, pathway analysis, and disease progression studies.

Unlike lentiviral pooled screens, Edit-R synthetic crRNA arrayed libraries enable one-gene-per-well investigation, using high-content assays to answer more in-depth biological questions. A CRISPRa-based system for overexpression studies also overcomes many of the shortcomings of early generations of DNA plasmid-encoded gene expression tools. By triggering the endogenous gene’s expression, the gene is transcribed in its native form, so researchers can be assured of highly relevant results in their cell system.

The Edit-R CRISPRa portfolio includes catalogue libraries for popular human and mouse gene families, such as ubiquitin enzymes, transcription factors, and kinases, in addition to druggable gene targets and the whole human genome. Bespoke collections are also available to support researchers working with a specialized gene target list.

Richard Vellacott, Interim Chief Executive Officer, Horizon Discovery, commented: “The expansion of Horizon’s already impressive portfolio of functional genomics screening libraries demonstrates our global leadership and commitment to continuing to address the needs of the research community. By providing advanced tools and services to support cutting-edge academic and drug discovery research, we are helping drive the genomic revolution.”
Advertisement